# eLQ vs SARCULATOR

The clearest difference is rating: SARCULATOR at 4.3 against eLQ's 4.0. SARCULATOR also leads on update cadence (every 7 months vs every 14 months) and ratings volume (3 vs 1). eLQ's advantage is iOS requirement (6.0 vs 13.0). On price, ads, in-app purchases and monetization model there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

SARCULATOR holds the better App Store score, 4.3 against 4.0. Both are backed by a comparable volume of ratings — 1 and 3 respectively.

eLQ ships an update every 14 months, SARCULATOR every 7 months. The most recent releases landed on September 18, 2026 and September 21, 2026 respectively.

## The numbers

| Metric | eLQ | SARCULATOR |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [4.0 (1 ratings)](https://appshunter.io/ios/app/elq/id398906906/reviews) | **[4.3 (3 ratings)](https://appshunter.io/ios/app/sarculator/id1052119173/reviews)** |
| Number of ratings | 1 | **3** |
| Positive reviews | 66.7% of reviews | — |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | Every 14 months | **Every 7 months** |
| Monetization | Free | Free |
| Size | 12 MB | 26 MB |
| Requires iOS | **6.0** | 13.0 |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 17+ | 12+ |
| Developer | [SFjRO](https://appshunter.io/developer/384465115) | [DIGITAL FOREST SRL](https://appshunter.io/developer/581246108) |

## What reviewers say

### eLQ

[App page](https://appshunter.io/ios/app/elq/id398906906)

This medical app calculates biological equivalent doses for radiation therapy using the linear-quadratic model. It allows users to select various organs and α/β ratios for precise calculations.

**Highlights:** Linear-quadratic model calculations, Selectable organs (spine, heart, lung, liver, skin), Adjustable α/β ratios, Biological equivalent dose computation

**Features:** macOS Compatibility

**In-app purchases:** none


### SARCULATOR

[App page](https://appshunter.io/ios/app/sarculator/id1052119173)

This medical tool provides physicians with predictive models for retroperitoneal and extremity sarcoma patients. It estimates overall survival and disease-free survival, serving as an informative resource to enhance physician predictive capabilities.

**Highlights:** Predictive models for sarcoma patients, Estimates 5-year overall survival, Estimates 5-year disease-free survival, Estimates 10-year overall survival, Estimates cumulative incidence of distant metastasis, Informative tool for physicians

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is eLQ free?

eLQ is free to download, with no in-app purchases.

### Is SARCULATOR free?

SARCULATOR is free to download, with no in-app purchases.

### Which has better reviews, eLQ or SARCULATOR?

SARCULATOR is rated higher. eLQ averages 4.0 out of 5 from 1 ratings, while SARCULATOR averages 4.3 from 3 ratings.

### Do eLQ or SARCULATOR have ads?

Neither eLQ nor SARCULATOR shows ads.

### Which is updated more often, eLQ or SARCULATOR?

eLQ ships an update every 14 months, and SARCULATOR every 7 months. Most recently, eLQ was updated on September 18, 2026 and SARCULATOR on September 21, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*